
DD Stock Forecast & Price Target
DD Analyst Ratings
Bulls say
DuPont de Nemours has demonstrated strong growth in its Healthcare and Water segments, with sales increasing in the high-single digits, driven by demand in medical packaging and biopharma solutions. The company’s focus on innovation, evidenced by a shift towards new products as indicated by a vitality index target of 45%, is expected to enhance both pricing and product mix in the coming years. Additionally, the Electronics & Industrial segment is poised for growth propelled by technological advancements such as 5G and IoT expansion, which further supports a positive long-term outlook for the company's valuation.
Bears say
DuPont de Nemours faces significant challenges due to delays in synergy realization following the merger and ongoing weakness in its key markets, particularly electronics and construction. These sectors are critical for the company, and their current performance raises concerns about DuPont’s ability to sustain profitability, especially as recovery in China remains sluggish. As healthcare and water sectors are projected to drive the majority of profits, the dependence on the performance of struggling segments presents a considerable risk to overall financial stability.
This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.
DD Analyst Forecast & Price Prediction
Start investing in DD
Order type
Buy in
Order amount
Est. shares
0 shares